逆流防止装置の世界市場：洞察、競合情勢、市場予測：2032年

逆流防止装置の市場規模は、2025年から2032年までの予測期間中に6.69%のCAGRで拡大すると予測されています。逆流防止装置に対する需要の増加は、主に脱水などの要因に関連することが多い腎臓結石の有病率の上昇によってもたらされています。さらに、腎臓結石開発の重要な危険因子である前立腺肥大症（BPH）、肥満、座りがちなライフスタイルなどの危険因子の負担が増加していることも、市場の成長にさらに寄与しています。主要企業による継続的な研究開発努力とともに、逆流防止装置の技術的進歩も、2025年から2032年までの予測期間中、逆流防止装置市場のプラス成長を推進する上で極めて重要な役割を果たしています。

腎結石（尿路結石症）の有病率の上昇は、逆流防止装置市場の拡大を促進する重要な要因です。2023年10月のKidney Research UKのデータによると、腎臓結石は英国では約10人に1人が罹患しています。

2023年のカナダ泌尿器学会のデータによると、カナダでは約10人に1人が人生のある時点で腎臓結石を発症します。この症状は女性よりも男性に多く、様々な地域で活発な症例が増加しています。このような腎臓結石の罹患率の増加が、関連医療機器・治療市場の成長を牽引しています。逆流防止装置は、腎結石の管理、特に尿管鏡検査や結石破砕などの処置の際に重要な役割を果たします。これらの装置は、治療中に結石片が腎臓に戻るのを防ぐために特別に設計されています。世界中で腎臓結石の症例数が増加していることから、逆流防止装置を含む高度な医療ソリューションに対する需要は今後も高まり続けると予想され、市場の拡大にさらに貢献しています。

腎臓結石の主要な危険因子である肥満と座りがちなライフスタイルの増加が、市場の成長をさらに後押ししています。2024年2月の世界保健機関（WHO）によると、2022年には世界で10億人以上が肥満の影響を受けており、その内訳は成人6億5,000万人、青年3億4,000万人、小児3,900万人となっています。この数は今後も増加すると予想され、腎臓結石治療に対する需要が高まり、市場成長の原動力となります。

しかし、装置関連の合併症のリスク、熟練した専門家の不足、低所得国における抗逆流装置へのアクセスの制限などの課題が、市場成長の抑制要因として作用する可能性があります。

当レポートでは、世界の逆流防止装置市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 抗逆流装置市場レポートのイントロダクション

第2章 逆流防止装置市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 抗逆流装置市場の主な要因分析

• 逆流防止装置市場の促進要因
• 逆流防止装置市場の抑制要因と課題
• 逆流防止装置市場の機会

第6章 逆流防止装置市場におけるポーターのファイブフォース分析

第7章 逆噴射防止装置の市場評価

• 製品タイプ別
  • 結石捕捉・抽出装置
  • 結石回収装置
  • その他
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 逆流防止装置市場の企業と製品プロファイル

• Boston Scientific Corporation
• Cook
• Rocamed
• Accordion Medical
• EndoTheia, Inc.
• KARL STORZ
• Olympus Corporation
• Coloplast Group
• Endotherapeutics Pty Ltd.
• ELMED Medical Systems
• PENTAX Medical
• UROMED Kurt Drews KG
• BD
• Dornier MedTech
• NeoScope Inc.
• OTU Medical
• Clarion Medical Technologies
• Calyxo, Inc.
• EMS Urology
• Happiness Works Medical

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Anti-retropulsion Devices Market in Global (2022-2032)
• Table 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
• Table 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
• Table 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
• Table 6: Anti-retropulsion Devices Market in North America (2022-2032)
• Table 7: Anti-retropulsion Devices Market in the United States (2022-2032)
• Table 8: Anti-retropulsion Devices Market in Canada (2022-2032)
• Table 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
• Table 10: Anti-retropulsion Devices Market in Europe (2022-2032)
• Table 11: Anti-retropulsion Devices Market in France (2022-2032)
• Table 12: Anti-retropulsion Devices Market in Germany (2022-2032)
• Table 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
• Table 14: Anti-retropulsion Devices Market in Italy (2022-2032)
• Table 15: Anti-retropulsion Devices Market in Spain (2022-2032)
• Table 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
• Table 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
• Table 18: Anti-retropulsion Devices Market in China (2022-2032)
• Table 19: Anti-retropulsion Devices Market in Japan (2022-2032)
• Table 20: Anti-retropulsion Devices Market in India (2022-2032)
• Table 21: Anti-retropulsion Devices Market in Australia (2022-2032)
• Table 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
• Table 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
• Table 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
• Table 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
• Table 26: Anti-retropulsion Devices Market in Africa (2022-2032)
• Table 27: Anti-retropulsion Devices Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Anti-retropulsion Devices Market in Global (2022-2032)
• Figure 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
• Figure 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
• Figure 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
• Figure 6: Anti-retropulsion Devices Market in North America (2022-2032)
• Figure 7: Anti-retropulsion Devices Market in the United States (2022-2032)
• Figure 8: Anti-retropulsion Devices Market in Canada (2022-2032)
• Figure 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
• Figure 10: Anti-retropulsion Devices Market in Europe (2022-2032)
• Figure 11: Anti-retropulsion Devices Market in France (2022-2032)
• Figure 12: Anti-retropulsion Devices Market in Germany (2022-2032)
• Figure 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
• Figure 14: Anti-retropulsion Devices Market in Italy (2022-2032)
• Figure 15: Anti-retropulsion Devices Market in Spain (2022-2032)
• Figure 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
• Figure 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
• Figure 18: Anti-retropulsion Devices Market in China (2022-2032)
• Figure 19: Anti-retropulsion Devices Market in Japan (2022-2032)
• Figure 20: Anti-retropulsion Devices Market in India (2022-2032)
• Figure 21: Anti-retropulsion Devices Market in Australia (2022-2032)
• Figure 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
• Figure 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
• Figure 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
• Figure 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
• Figure 26: Anti-retropulsion Devices Market in Africa (2022-2032)
• Figure 27: Anti-retropulsion Devices Market in South America (2022-2032)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 due to the growing prevalence of kidney stones and increasing R&D activiites and product launches in anti-retropulsion devices.

The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032. The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

Anti-retropulsion Devices Market Dynamics:

The growing prevalence of kidney stones (urolithiasis) is a key factor driving the expansion of the anti-retropulsion devices market. According to Kidney Research UK data from October 2023, kidney stones affect approximately one in ten individuals in the United Kingdom.

According to data from the Canadian Urological Association in 2023, approximately one in ten people develop a kidney stone at some point in their life in Canada. This condition is more prevalent in men than in women, with active cases on the rise in various regions. This increasing incidence of kidney stones is driving the growth of the market for related medical devices and treatments. Anti-retropulsion devices play a critical role in the management of kidney stones, particularly during procedures like ureteroscopy and lithotripsy. These devices are specifically designed to prevent the migration of stone fragments back into the kidney during treatment. With the growing number of kidney stone cases worldwide, the demand for advanced medical solutions, including anti-retropulsion devices, is expected to continue rising, further contributing to the market's expansion.

The growing incidence of obesity and sedentary lifestyles-key risk factors for kidney stones-further drives market growth. According to the World Health Organization (WHO) in February 2024, over 1 billion people worldwide were affected by obesity in 2022, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to rise, creating a greater demand for kidney stone treatments, thereby driving the market growth.

However, challenges such as the risk of device-related complications, lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries may act as barriers to market growth.

Anti-retropulsion Devices Market Segment Analysis:

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the anti-retropulsion devices, stone entrapment and extraction devices are expected to capture the largest market share during the forecast period. The is attributed to various advantages associated with these devices. Stone entrapment and extraction devices are highly effective tools for removing kidney stones from the urinary tract, while also minimizing the risk of stone migration.

These devices offer minimally invasive solutions, meaning smaller incisions or no incisions at all, which results in less pain, a lower risk of infection, and quicker recovery times compared to traditional open surgery. For larger stones or those located in difficult-to-reach areas, stone extraction through entrapment proves to be particularly beneficial. These devices are designed to fragment stones into smaller pieces, making them easier to remove or pass naturally, reducing the need for more invasive procedures. This approach not only improves patient comfort but also contributes to more efficient treatment outcomes, promoting faster recovery and preserving overall kidney function.

Stone entrapment and extraction devices also play a crucial role in preventing the proximal migration of stones and fragments during ureteroscopy. This is essential for maintaining visibility and access to the stone, ensuring that the procedure is efficient and reduces the risk of complications associated with stone migration back into the kidney. For instance, devices like the EscapeTM Nitinol Stone Retrieval Device by Boston Scientific are specifically designed to facilitate smoother procedures by minimizing retropulsion, a common issue that can lead to longer operative times and increased procedure complexity.

In addition, the innovative technologies within the stone entrapment and extraction devices category, combined with their growing applications in urological procedures, are expected to significantly drive market growth. As the demand for more effective treatment solutions increases, the anti-retropulsion devices market is set to expand further throughout the forecast period.

North America is expected to dominate the overall anti-retropulsion devices market:

North America is projected to dominate the anti-retropulsion devices market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

According to data from the American Kidney Fund (2024), over 1 in 10 men and approximately 1 in 14 women in the United States experienced kidney stones at least once in their lifetime. Additionally, data from the National Institutes of Health (NIH) in 2023 highlighted that kidney stone affects 1 in 11 people, with an estimated 600,000 new cases reported in the United States annually. The rising prevalence of kidney stones is significantly driving the growth of the anti-retropulsion devices market in the region.

The increasing incidence of upper tract urothelial carcinoma (UTUC) and kidney diseases is also a significant driver for the growing demand for anti-retropulsion devices. Patients with urinary cancers and other urinary tract conditions face an elevated risk of developing renal stones, exacerbating the need for effective anti-retropulsion interventions. According to data from the Center for Disease Control and Prevention (CDC) published in June 2024, approximately 35 million cases of chronic kidney disease (CKD) were reported in the United States in 2023. CKD impairs kidney function, leading to the formation and accumulation of renal stones, thereby fueling demand for anti-retropulsion devices and promoting market expansion.

Anti-retropulsion Devices Market Key Players:

Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

Recent Developmental Activities in the Anti-retropulsion Devices Market:

• In November 2024, EndoTheia, Inc., a frontrunner in innovative surgical technology, announced the successful completion of the first-in-human clinical trial for its FlexStone(TM) Basket. The cutting-edge device provides unmatched flexibility and control, allowing for the retrieval of stones from difficult-to-reach and challenging locations, thereby enhancing the precision and effectiveness of stone removal procedures. The success of this trial marked a significant milestone in advancing minimally invasive treatments for kidney stones.

Key Takeaways from the Anti-retropulsion Devices Market Report Study

• Market size analysis for current Anti-retropulsion Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Anti-retropulsion Devices market.
• Various opportunities are available for the other competitors in the Anti-retropulsion Devices Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Anti-retropulsion Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Anti-retropulsion Devices market growth in the coming future?

Target Audience who can be benefited from this Anti-retropulsion Devices Market Report Study

• Anti-retropulsion Devices product providers
• Research organizations and consulting companies
• Anti-retropulsion Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Anti-retropulsion Devices
• Various end-users who want to know more about the Anti-retropulsion Devices Market and the latest technological developments in the Anti-retropulsion Devices Market.

Frequently Asked Questions for the Anti-retropulsion Devices Market:

1. What are Anti-retropulsion Devices?

• Anti-retropulsion devices for kidney stones are medical instruments designed to prevent the backward movement (retropulsion) of kidney stones during minimally invasive procedures, such as ureteroscopy or lithotripsy. When a stone is being fragmented or removed, there is a risk that it could move away from the targeted area, potentially causing complications or making the procedure less effective.

2. What is the market for ureteroscopes?

• The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032.

3. What are the drivers for the Anti-retropulsion Devices market?

• The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anti-retropulsion Devices market?

• Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

5. Which region has the highest share in the Anti-retropulsion Devices market?

• North America is projected to dominate the ureteroscope market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

Table of Contents

1. Anti-retropulsion Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Anti-retropulsion Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Anti-retropulsion Devices Market Key Factors Analysis

• 5.1. Anti-retropulsion Devices Market Drivers
  • 5.1.1. The growing prevalence of kidney stones
  • 5.1.2. The growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles
  • 5.1.3. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players
• 5.2. Anti-retropulsion Devices Market Restraints and Challenges
  • 5.2.1. Risks of device-associated complications
  • 5.2.2. Lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries
• 5.3. Anti-retropulsion Devices Market Opportunity
  • 5.3.1. Shift towards minimally invasive procedures

6. Anti-retropulsion Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Anti-retropulsion Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Stone Entrapment and Extraction Devices
  • 7.1.2. Stone Retrieval Devices
  • 7.1.3. Others
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centers
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.1.2. Canada Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.1.3. Mexico Anti-retropulsion Devices Market Size in USD million (2022-2032)
  • 7.3.2. Europe
    • 7.3.2.1. France Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2.2. Germany Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2.3. United Kingdom Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2.4. Italy Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2.5. Spain Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2.6. Rest of Europe Anti-retropulsion Devices Market Size in USD million (2022-2032)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3.2. Japan Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3.3. India Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3.4. Australia Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3.5. South Korea Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3.6. Rest of Asia-Pacific Anti-retropulsion Devices Market Size in USD million (2022-2032)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.4.2. Africa Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.4.3. South America Anti-retropulsion Devices Market Size In USD Million (2022-2032)

8. Anti-retropulsion Devices Market Company and Product Profiles

• 8.1. Boston Scientific Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Cook
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Rocamed
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Accordion Medical
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. EndoTheia, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. KARL STORZ
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Olympus Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Coloplast Group
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Endotherapeutics Pty Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. ELMED Medical Systems
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. PENTAX Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. UROMED Kurt Drews KG
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. BD
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Dornier MedTech
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. NeoScope Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. OTU Medical
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Clarion Medical Technologies
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Calyxo, Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. EMS Urology
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Happiness Works Medical
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us